Zim Laboratories share news, announcements and annual reports
NSE: ZIMLABBSE: 541400Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 28 Oct 2026. Previous close ₹133.82.
28 Oct: open ₹130.35, high ₹143.29, low ₹130.01
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹758 Cr1,933rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 205.08
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.56
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 1.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 1.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.42
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,24,34441.6% delivered
Zim Laboratories has 223 announcements on record, routine notices left out; 3 in the 30 days to 28 Oct 2026, the latest on 28 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Zim Laboratories quarterly results
The board meets on 4 Nov 2026 to consider financial results
Notice filed 28 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
Zim Laboratories annual reports, presentations and earnings calls
The company's own documents, latest first.Zim Laboratories financials, year by year
Annual reports4
- Annual report, year to Mar 20265 Jun 2026
- Annual report, year to Mar 20255 Jun 2025
- Annual report, year to Mar 20245 Jun 2024
- Annual report, year to Mar 202316 Jun 2023, a zip file
Investor presentations16
- Earnings Presentation - Q1 FY276 Aug 2026
- Earnings presentation for Q4 & FY2619 May 2026
- Investor Presentation11 Feb 2026
- Investor Presentation12 Nov 2025
- Investor Presentation7 Aug 2025
11 earlier presentations
- Investor Presentation20 May 2025
- Earnings Presentation - Q2 & H1 FY259 Nov 2024
- Investor Presentation30 Aug 2024
- Earnings Presentation - Q1 FY253 Aug 2024
- Earnings Presentation for Q4 & FY2413 May 2024
- Q3 & 9MFY24 - Earnings Presentation29 Jan 2024
- Q2 & H1FY24 Earnings Presentation1 Nov 2023
- Investor Presentation15 Aug 2023
- Investor Presentation20 May 2023
- Disclosure under Reg. 30 of SEBI (LODR) Regulations- Business Presentation13 Feb 2023
- Corporate Presentation - 9M F.Y. 2022-233 Feb 2023
Earnings calls24
- Transcript12 Aug 2026
- Link of Recording8 Aug 2026
- Transcript23 May 2026
- Link of Recording20 May 2026
- Transcript17 Feb 2026
19 earlier call documents
- Link of Recording13 Feb 2026
- Transcript17 Nov 2025
- Link of Recording15 Nov 2025
- Transcript14 Aug 2025
- Link of Recording12 Aug 2025
- Transcript26 May 2025
- Link of Recording22 May 2025
- Transcript15 Nov 2024
- Link of Recording11 Nov 2024
- Transcript20 May 2024
- Link of Recording15 May 2024
- Transcript5 Feb 2024
- Link of Recording31 Jan 2024
- Transcript15 Nov 2023
- Link of Recording9 Nov 2023
- Transcript21 Aug 2023
- Link of Recording16 Aug 2023
- Transcript25 May 2023
- Link of Recording22 May 2023
Zim Laboratories share news and announcements
Newest first. Page 1 of 5.
Oct 2026
28 Oct · Board meeting
8 Oct · Rating
Sep 2026
18 Sep
15 Sep
Aug 2026
6 Aug · Results
4 Aug · Analysts
Jul 2026
31 Jul · Board meeting
10 Jul · Meeting
Jun 2026
30 Jun · Analysts
30 Jun · Analysts
29 Jun · Meeting
29 Jun · Meeting
15 Jun · Analysts
13 Jun · Analysts
5 Jun · General Updates
5 Jun · Meeting
May 2026
19 May · Management
19 May · Results
13 May · Analysts
12 May · Board meeting
8 May · Disclosure
8 May
Apr 2026
18 Apr · Disclosure
9 Apr · General Updates
Mar 2026
30 Mar · Management
17 Mar · Updates
16 Mar · Analysts
Feb 2026
23 Feb · General Updates
17 Feb · Rating
11 Feb · Board meeting
11 Feb · Legal
11 Feb
11 Feb · Results
11 Feb · Board meeting
6 Feb · Analysts
5 Feb · Board meeting
2 Feb · Management
Jan 2026
21 Jan · Board meeting
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 9 Oct 2026Credit ratingup 7.07%+5.9 pts vs Nifty 500market median 0.0% · five sessions −0.2% (−2.8 pts vs Nifty 500) · volume 3.2× usual · delivery −26.4 pts against usual · The announcement
- 6 Aug 2026Resultsup 0.60%+0.6 pts vs Nifty 500market median −0.7% · five sessions −5.7% (−5.4 pts vs Nifty 500) · volume 3.3× usual · The announcement
- 20 May 2026Resultsdown 1.47%−1.7 pts vs Nifty 500market median −0.7% · five sessions +2.8% (+1.1 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 18 Feb 2026Credit ratingup 2.36%+1.9 pts vs Nifty 500market median 0.0% · five sessions −3.4% (−2.4 pts vs Nifty 500) · volume 1.4× usual · delivery +20.5 pts against usual · The announcement
- 12 Feb 2026Resultsdown 2.22%−1.7 pts vs Nifty 500market median −0.7% · five sessions −5.7% (−5.1 pts vs Nifty 500) · volume 1.4× usual · delivery −3.2 pts against usual · The announcement
- 3 Feb 2026Board or managers changeddown 0.43%−3.1 pts vs Nifty 500market median 0.0% · five sessions −2.9% (−6.6 pts vs Nifty 500) · volume 0.5× usual · delivery −4.9 pts against usual · The announcement
- 13 Nov 2025Resultsdown 4.35%−4.3 pts vs Nifty 500market median −0.7% · five sessions −4.2% (−4.5 pts vs Nifty 500) · volume 0.4× usual · delivery −12.6 pts against usual · The announcement
- 22 Sep 2025Board or managers changedup 0.01%+0.5 pts vs Nifty 500market median 0.0% · five sessions −2.6% (+0.6 pts vs Nifty 500) · volume 0.4× usual · delivery +11.5 pts against usual · The announcement
- 8 Aug 2025Resultsdown 4.53%−3.4 pts vs Nifty 500market median −0.7% · five sessions −7.3% (−7.2 pts vs Nifty 500) · volume 0.3× usual · delivery +4.3 pts against usual · The announcement
- 1 Apr 2025Board or managers changedup 4.38%+5.6 pts vs Nifty 500market median 0.0% · five sessions +6.0% (+11.8 pts vs Nifty 500) · volume 0.2× usual · delivery −24.3 pts against usual · The announcement
11 earlier announcements
- 25 Nov 2024Credit ratingup 2.17%+0.7 pts vs Nifty 500market median 0.0% · five sessions +9.5% (+7.4 pts vs Nifty 500) · volume 0.8× usual · delivery −7.6 pts against usual · The announcement
- 11 Nov 2024Resultsdown 5.89%−5.6 pts vs Nifty 500market median −0.7% · five sessions −8.3% (−5.0 pts vs Nifty 500) · volume 0.9× usual · delivery −2.9 pts against usual · The announcement
- 11 Nov 2024Board or managers changeddown 5.89%−5.6 pts vs Nifty 500market median 0.0% · five sessions −8.3% (−5.0 pts vs Nifty 500) · volume 0.9× usual · delivery −2.9 pts against usual · The announcement
- 10 Oct 2024Credit ratingup 0.26%+0.3 pts vs Nifty 500market median 0.0% · five sessions +6.7% (+6.4 pts vs Nifty 500) · volume 0.3× usual · delivery 0.0 pts against usual · The announcement
- 5 Aug 2024Resultsdown 3.81%−0.7 pts vs Nifty 500market median −0.7% · five sessions −4.8% (−3.4 pts vs Nifty 500) · volume 2.4× usual · delivery +4.7 pts against usual · The announcement
- 5 Aug 2024Board or managers changeddown 3.81%−0.7 pts vs Nifty 500market median 0.0% · five sessions −4.8% (−3.4 pts vs Nifty 500) · volume 2.4× usual · delivery +4.7 pts against usual · The announcement
- 4 Jun 2024Board or managers changeddown 7.96%−1.2 pts vs Nifty 500market median 0.0% · five sessions +2.0% (+1.9 pts vs Nifty 500) · volume 0.8× usual · delivery +1.5 pts against usual · The announcement
- 8 Apr 2024Credit ratingdown 1.48%−2.0 pts vs Nifty 500market median 0.0% · five sessions −5.5% (−4.3 pts vs Nifty 500) · volume 0.6× usual · delivery −9.0 pts against usual · The announcement
- 3 Jul 2023Credit ratingup 1.88%+1.3 pts vs Nifty 500market median 0.0% · five sessions −5.5% (−6.3 pts vs Nifty 500) · volume 0.4× usual · delivery −9.5 pts against usual · The announcement
- 7 Jun 2023Credit ratingup 5.09%+4.3 pts vs Nifty 500market median 0.0% · five sessions +8.7% (+7.6 pts vs Nifty 500) · volume 3.8× usual · delivery −13.3 pts against usual · The announcement
- 12 Apr 2023Credit ratingdown 1.54%−2.0 pts vs Nifty 500market median 0.0% · five sessions +5.8% (+5.8 pts vs Nifty 500) · volume 2.5× usual · delivery +6.7 pts against usual · The announcement
Zim Laboratories results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.